PDI Povidone-Iodine Swabstick
SubPotent: Out of Specification
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk.
992 FDA drug recalls with this cause, newest first.
These recalls cover sub-potent or super-potent products, or a failed content-uniformity test - meaning some pills in the same batch held noticeably different amounts of active ingredient than others. Either way it is a direct dosing risk: too little to work, or too much and harmful. Thyroid hormones and compounded injectables are the classic examples, because their dose window is narrow.
SubPotent: Out of Specification
SubPotent: Out of Specification
SubPotent: Out of Specification
SubPotent: Out of Specification
Subpotent
Low out of specification results for epinephrine assay.
Subpotent
Superpotent
Subpotent
Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug
Superpotent Drug
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Subpotent
Superpotent Drug. Lidocaine higher concentration than listed
Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
Subpotent drug
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.